Archive for July, 2008

New gene clues to schizophrenia risk (AFP)

Wednesday, July 30th, 2008

PARIS (AFP) - Three studies published on Wednesday unveil flaws in several chromosomes that highlight an inherited vulnerability to schizophrenia. (Read the full post about ‘New gene clues to schizophrenia risk (AFP)’…)

Few aware that smoking can cause bladder cancer (Reuters)

Wednesday, July 30th, 2008

NEW YORK (Reuters Health) - While most family know that smoking can cause lung cancer, a new study shows that few know that it is a major risk factor for bladder cancer — even among people who have the disease.

In a research review published in the Journal of Urology, investigators found that in single recent study, just over one third of adults knew that smoking raises the put to hazard of bladder cancer.

(Read the full post about ‘Few aware that smoking can cause bladder cancer (Reuters)’…)

Medivation Alzheimer’s drug helps — if used early (Reuters)

Wednesday, July 30th, 2008

CHICAGO (Reuters) - A drug for Alzheimer's disease made by Medivation Inc kept symptoms at bay for 18 months, U.S. researchers said on Wednesday, but people who got the drug after first taking a placebo fared less well, suggesting in good season treatment is best.

The latest results, being presented at the Alzheimer's Association's international meeting in Chicago, found Dimebon was safe and continued to benefit people who took it for a year and a half.

"The most important thing from my point of view is there were no recent safety issues that emerged with longer exposure of the patients," declared Dr.

(Read the full post about ‘Medivation Alzheimer’s drug helps — if used early (Reuters)’…)

Baxter Alzheimer’s drug effective at 9 months: study (Reuters)

Wednesday, July 30th, 2008

CHICAGO (Reuters) - Alzheimer's disease patients treated with Baxter International Inc's Gammagard for nine months maintained cognitive function and in some cases improved it, according to an interim analysis of data from a small study.

"If successful, it should in reality alter the long-term course of the illness, and the effects should persist for a very long time," Dr.

(Read the full post about ‘Baxter Alzheimer’s drug effective at 9 months: study (Reuters)’…)

Advances Made Against Alzheimer’s Disease (HealthDay)

Wednesday, July 30th, 2008

WEDNESDAY, July 30 (HealthDay news)– New reports on very different approaches to treating Alzheimer's disease could one day lead to better therapies for the mind-robbing condition, experts say.

A trio of studies that were expected to be presented Wednesday at the Alzheimer's Association 2008 International Conference on Alzheimer's Disease in Chicago noted stay made on three different treatment fronts.

The first finding involved a trial of a drug called dimebon, an antihistamine widely available in Russia, that is being tried for Alzheimer's disease even though there is no theoretical basis for its use in treating this condition.

"We don't understand what the mechanism of exploit is," said Dr.

(Read the full post about ‘Advances Made Against Alzheimer’s Disease (HealthDay)’…)

Moms With Alzheimer’s May Pass on Risk to Kids (HealthDay)

Wednesday, July 30th, 2008

WEDNESDAY, July 30 (HealthDay news) — People whose mothers have had Alzheimer's disease may be predisposed to the mind-robbing condition, a new study finds.

The link may be a dysfunction in how the brain handles sugar — something that's probably genetic and starts years before symptoms of Alzheimer's appear, researchers say.

"Overall, these findings show that their brains are not working properly to start with, and the metabolic impairment gets worse over time," explained precedence researcher Lisa Mosconi, a research assistant professor of psychiatry at the Center for Brain Health at NYU Langone Medical Center in New York City.

There is evidence that having a parent affected with Alzheimer's disease increases the risk of developing Alzheimer's disease four- to tenfold, Mosconi said.

(Read the full post about ‘Moms With Alzheimer’s May Pass on Risk to Kids (HealthDay)’…)

Missing DNA chunks tied to schizophrenia risk (AP)

Wednesday, July 30th, 2008

NEW YORK - Two huge international studies show that people who lack certain chunks of DNA run a dramatically higher risk of getting schizophrenia, a finding that could help exposed strange doors to understanding and diagnosing the disease.

These deletions are rare, both found in less than 1 percent of schizophrenia patients. But each one boosts the risk of disease through as much as 15-fold, by dint of. one estimate.

Scientists said studying such abnormalities may help them find new medications by shedding light on what causes the disease.

(Read the full post about ‘Missing DNA chunks tied to schizophrenia risk (AP)’…)

Brazil’s success in AIDS fight depends on cheap drugs (AFP)

Wednesday, July 30th, 2008

RIO DE JANEIRO (AFP) - Brazil, long considered a model country in the fight against AIDS, depends on cheap retroviral treatments secured from the big drug companies after fierce struggle. (Read the full post about ‘Brazil’s success in AIDS fight depends on cheap drugs (AFP)’…)

Bush signs housing bill as Fannie Mae grows (Reuters)

Wednesday, July 30th, 2008

WASHINGTON (Reuters) - U.S. President George W. Bush on Wednesday signed into law a sweeping rescue bale aimed at resurrecting the housing market from its worst crisis since the Great Depression and stabilizing the two largest mortgage finance companies.

The new law launches a $300 billion government initiative to refinance troubled mortgages, and boosts oversight of Fannie Mae and Freddie Mac, which own or guarantee almost half the country's $12 trillion in home mortgage debt.

It expands a line of U.S.

(Read the full post about ‘Bush signs housing bill as Fannie Mae grows (Reuters)’…)

New Prostate Cancer Drug Shows Promise (American Cancer Society)

Wednesday, July 30th, 2008

Promising–yet preliminary–results from an early clinical trial explain that the experimental drug abiraterone can significantly reduce the size of prostate cancer tumors in men who haven’t responded to other therapies.

Researchers from the Royal Marsden NHS Foundation Trust and the Institute of Cancer Research in the United Kingdom recruited 21 men with late-stage prostate cancer who were no longer responding to hormone therapy and prescribed a once-a-day regimen of the pill abiraterone.

(Read the full post about ‘New Prostate Cancer Drug Shows Promise (American Cancer Society)’…)